LAMINAR FLOW BENCH GUIDELINES

Similar documents
MFA Inc Compliance with the Food Safety Modernization Act. Jim S White PhD Director, Livestock Nutrition MFA Inc Columbia, MO

Where Quality Meets Flexibility

Current Trends in Sterile Manufacturing. by Sterling Kline, RA Director of Project Development Integrated Project Services (IPS)

Unit 208 Assist with the manufacture and assembly of medicinal products

Industry Perspective on Manufacturing in Early Development

Industry Perspective on PET Manufacturing Comparison of EU and US

Production and Test Facilities Via Romagnoli, Fiorenzuola d Arda (PC) - Italy - Tel Fax Containment Systems

Survival Kit for Regulatory Inspections

Webinar Expert Module 3: GMP Inspections Dupont

GMP Requirements. Gabriel Kaddu, Senior GMP Specialist Promoting the Quality of Medicines Program (PQM) U.S. Pharmacopeial Convention (USP)

1972: Founded to manufacture laminar flow cabinets and design and build cleanrooms

Laboratory Safety. Marlia Singgih Wibowo School of Pharmacy ITB

ABOUT HAMELN PHARMA About us

Subpart B Organization and Personnel, 21 CFR Responsibilities of the quality control unit.

Prequalification Team Inspection services WHO PUBLIC INSPECTION REPORT (WHOPIR) Finished Product Manufacturer. Tablets

Overview of Regulatory Requirements for API and Formulations


9/19/2013 DISCUSSION POINTS COMPOUNDING INDUSTRY TRENDS

HVAC and Risk Management RACI Meeting 7 th December Agenda. Design. Project Management. Context. Qualification. Construction

GMP & Quality Assurance. Mayur Sushir Dept of Microbiology MJC

INSPECTOR S OBSERVATIONS AND WARNING LETTER

Receive Pharmaceutical Stock

Quality Risk Management (ICH Q9): WHO Model for Sustainable Quality Medicines

Containment Booths. FOR MORE INFORMATION ON CONTAINMENT BOOTHS CALL +44 (0) OR

Baxa Corporation. Technical Paper. Environmental Controls for Sterile Compounding

Basic Principles of GMP. Sanitation and Hygiene

MEDICINES CONTROL COUNCIL

TITLE: Research Pharmacy Standard Policy SOP #: INV-100 Page: 1 of 5 Effective Date: 8/31/17

Good Manufacturing Practices. Single Points of Contact. Surveillance and Monitoring. Good Distribution Practices. Track and Trace System

ACHIEVING WORLD STANDARDS THROUGH QUALITY IN PROCESS. Presented by, Nimish Shroff (Director) M/s. Charak Pharma Pvt. Ltd.

BSWH Technician Continuing Education 2016 Part 2: Pharmacy Law - Controlled Substance Security & Drug Supply Chain Security Act (DSCSA) Contact

Overview. A brief from

CGMP Requirements for Investigational Products

Standard Operating Procedures Guidelines for Good Clinical Practice

AIR FLOW SYSTEM CATALOGUE. clean rooms

WHAT IS A CLEAN ROOM?

Application Note. Consistent Formulation Quality Preventing Errors in the Dispensing Room

I. Purpose. II. Definitions. Last Approval Date

STANDARDS FOR COMPOUNDING PHARMACIES

Prequalification of Medicines Programme

Technical Report No. 63 Quality Requirements for the Extemporaneous Preparation of Clinical Trial Materials

Deficiencies found in Inspections and QP Responsibilities

MANUFACTURE OF INVESTIGATIONAL MEDICINAL PRODUCTS

Beamex CMX Calibration Software and GAMP - Good Automated Manufacturing Practices

Journal of Chemical and Pharmaceutical Research

Standard Operating Procedures

Re: Insanitary Conditions at Compounding Facilities, Guidance for Industry (Docket ID: FDA-2016-D )

Webinar. The New EU-GMP Annex 1 draft Dupont. GOP-Innovations your Partner for Practical Training and e-learning. 8 June 2018

Consulted With Post/Committee/Group Date Jane Giles Chief Pharmacist 22/09/2014 Professionally Approved By Dr A Jackson MMSG Chairman s action

COMPLIANCE DATES. Preventive Controls. CGMP Compliance Date. Business Size. Business other than Small and Very Small employees

A Guide to Food Safety Systems for Wineries as Required by FSMA

USP Chapter 823 USP 32 (old) vs. USP 35 (new)

Pharmaceutical Industry s Approach to Safe Handling of New Molecular Entities

This article is limited to the principles of

Introduction to GMPs and Validation WILLIAM GARVEY AND ASSOCIATES

EUROPEAN INDUSTRIAL PHARMACISTS GROUP. Guidance on CPD for QUALIFIED PERSONS

Compounding Aseptic Isolators (CAI) James T Wagner

Prequalification of Medicines Programme

Auditing Your Laboratory for Compliance with the FDA Dietary Supplement GMP s

Prequalification Team WHO PUBLIC INSPECTION REPORT Vaccine Manufacturer

Good Manufacturing Practices Purpose and Principles of GMP. Tony Gould

Good Distribution Practices Toolkit Change Control 10 March 2016

Pharmaceutical cgmps for the 21st Century February 2004

Manual 058 Out of Specification Results Investigation

Breakout Session A. Asset Management Best Practices and What Trends You Should Know (ISO 55000: Asset Management)

BRIEFING 1168 Compounding for Phase I Investigational Studies,

Testimony of Molly Ventrelli Vice President, Regulatory Affairs Fresenius Kabi USA, LLC

ECTU Central Office SOP ECTU_TM_17 Management of Trial (IMP) Supplies

Maintaining the blind for clinical trials in Pharmacy

Guidance on Requirements of the Sponsor and the Investigator as a Sponsor

CLASS I MICROBIOLOGICAL SAFETY CABINET - BIO 1

PAI Inspections, Observations and Data Integrity

Quality Agreements and Managing Contract Supplier Quality

Pharmaceutical Marketing

NHS Tayside Effective Date: 24/7/2009

The ABCs and Challenges of GMP The American Experience

Standard Operating Procedure. SOP effective: 19 February 2016 Review date: 19 February 2018

ICH Q8/Q8(R)

116th Annual Convention

An Overview of Established Practices and Parameters to Ensure Quality of a Pharmaceutical Product

Topics summarised in this presentation are: method for defining quality level you want meaning of external controls quality assurance activities

Drug Quality Assurance: Systems at ChemCon Author: Dr. Peter Gockel

Effective Quality Oversight of Pharmaceutical Contract Manufacturing Organizations (COM) COURSE DESCRIPTION

Relevant State and Federal statutory requirements are to be complied with.

Engineering & Validation Training Program

Full time (with occasional weekend working required)

Shortages of medicinal products due to manufacturing and quality problems

USP800: A quick summary and disposal. Brenda Denson, Pharm.D.

Annex 4. Guidance on good manufacturing practices: inspection report. Background

9. EEA Qualified Pharmacy Technician Assessment Framework

V. S. International Pvt. Ltd

St. Luke s University Health Network

GMP On Site Series. GMP Essentials

Food Safety Modernization Act: How will it Impact Your Business? Henry Turlington, PhD Director, Quality & Manufacturing Regulatory Affairs

CUSTOMER AND SUPPLIER ROLES AND RESPONSIBILITIES FOR 21 CFR 11 COMPLIANCE ASSESSMENT. 21 CFR Part 11 FAQ. (Frequently Asked Questions)

Design Considerations for TGA Licensed Pharmacies. Presented by Ashley Isbel 11 th August 2015

Table of Contents. Welcome to Dishman. Our Mission. Our Focus: Client Satisfaction

Dr. Sheelpriya walde Professor Gurunanak college of pharmacy, Nagpur

Supersedes Division Name Revision No. 0 Export Division Page No. 1 of 9

Management and Accountability of Investigational Medicinal Products in the King s Clinical Research Facility

Transcription:

LAMINAR FLOW BENCH GUIDELINES 4.2.6 Personnel should not be a source of contamination. 4.2.7 Directional airflow within production or packing areas should assist in preventing contamination. Airflows should be planned in conjunction with operator locations, so as to minimize contamination of the product by the operator and also to protect the operator from dust inhalation. 4.2.8 HVAC air distribution components should be designed, installed and located to prevent contaminants generated within the room from being spread. 4.2.9 Supply air diffusers of the high induction type (e.g. those typically used for office-type air-conditioning) should where possible not be used in clean areas where dust is liberated. Air diffusers should be of the non-induction type, introducing air with the least amount of induction so as to maximize the flushing effect. (See Figs 9 11 for illustrations of the three types of diffuser.) 4.2.10 Whenever possible, air should be exhausted from a low level in rooms to help provide a flushing effect. 4.3 Unidirectional airflow 4.3.1 Unidirectional airflow (UDAF) should be used where appropriate to provide product protection by supplying a clean air supply over the product, minimizing the ingress of contaminants from surrounding areas. 4.3.2 Where appropriate, the unidirectional airflow should also provide protection to the operator from contamination by the product. 4.3.3 Sampling of materials such as starting materials, primary packaging materials and products, should be carried out in the same environmental conditions that are required for the further processing of the product. 4.3.4 In a weighing booth situation, the aim of the design using UDAF should be to provide dust containment. 4.3.5 A dispensary or weighing booth should be provided with unidirectional airflow for protection of the product and operator.

4.3.6 The source of the dust and the position in which the operator normallystands should be determined before deciding on the direction of unidirectional flow. Example: In Fig. 12 the dust generated at the weighing station is immediately extracted through the perforated worktop, thus protecting the operator from dust inhalation, but at the same time protecting the product from contamination by the operator by means of the vertical unidirectional airflow stream. 4.3.7 The unidirectional flow velocity should be such that it does not disrupt the sensitivity of balances in weighing areas. Where necessary the velocity may be reduced to prevent inaccuracies during weighing, provided that sufficient airflow is maintained to provide containment. 4.3.8 The position in which the operator stands relative to the source of dust liberation and airflow should be determined to ensure that the operator is not in the path of an airflow that could lead to contamination of the product (Fig. 13). 4.3.9 Once the system has been designed and qualified with a specific layout for operators and processes, this should be maintained in accordance with an SOP. 4.3.10 There should be no obstructions in the path of a unidirectional flow airstream that may cause the operator to be exposed to dust. Fig. 14 illustrates the incorrect use of a weighing scale which has a solid back. The back of the weighing scale should not block the return air path as this causes air to rise vertically, resulting in a hazardous situation for the operator. Fig. 15 illustrates a situation where an open bin is placed below a vertical unidirectional flow distributor. The downward airflow should be prevented from entering the bin, and then being forced to rise again, as this would carry dust up towards the operator s face. Fig. 16 shows that a solid worktop can sometimes cause deflection of the vertical unidirectional airflow resulting in a flow reversal. A possible solution would be to have a 100 mm gap between the back of the table and the wall, with the air being extracted here.

4.3.11 The manufacturer should select either vertical or horizontal unidirectionalflow (Fig. 17) and an appropriate Airflow pattern to provide the best protection for the particular application.

Current Good Manufacturing Practice (cgmp) Compliance Directional Airflow Devices) (for The area of cgmp compliance covers many aspects of the devices specification.one of the most potentially serious areas of concern to a

visiting regulatory inspectors the risk of cross contamination. There are three different possibilities: Categorization of Compounds Most of the theory of compound categorization was developed in the USA. Companies such as Eli Lilly and Syntex who pioneered the application of differing containment devices realized that categorizing their compounds into three or four simple groups made the engineers and pharmacists focus on the relevant technology rather than an over engineered solution. As pharmaceutical compounds all have differing characteristics, the operator exposure level (OEL) based categorization in Table 6.5 outlines a simple categorization. Some compounds are dermal or respiratory sensitizers which means that certain workers will be more susceptible to an adverse reaction. Other compounds may have a cumulative effect. The examples given in Table 6.6, therefore, are guidelines. Principles of Bulk Dispensing The modern dispensary facility in a pharmaceutical plant must be capable of: Dispensing raw materials to a registered formulation that will be manufactured into a product for either pharmacy or hospital use. The

exception to this is a dispensary for research and development, or clinical trials of a product where other considerations may apply. Providing records that enable a complete audit trail of all the materials dispensed. This must include both pharmaceutical materials and packaging components. However, packaging components are usually dispensed and reconciled at the beginning and end of a packaging operation in a separate area. Here we will not consider these aspects further. In today s modern plant there will probably be a stock control and/or a warehouse management system in place. These are also manufacturing facilities which use factory management systems, sometimes referred to as MRP systems (material resource planning). At all times regulations under the Health and Safety Executive, MCA and FDA (if applicable) must be strictly followed. In addition all rules pertaining to Good Manufacturing Practice (GMP) must be obeyed. Standard operating procedures (SOPs) are subject to the validation procedure and all documentation relating to this must be kept secure. My special thanks to askaboutvalidation group. Durga prasad